化学
克拉斯
药物发现
计算生物学
对映体
虚拟筛选
配体(生物化学)
化学生物学
药物开发
组合化学
立体化学
药品
生物化学
药理学
生物
突变
受体
基因
作者
Yan Jiang,Chunlin Zhuang,Long Chen,Junjie Lu,Guoqiang Dong,Zhenyuan Miao,Wannian Zhang,Jian Li,Chunquan Sheng
标识
DOI:10.1021/acs.jmedchem.7b01243
摘要
Structural biology is a powerful tool for investigating the stereospecific interactions between a protein and its ligand. Herein, an unprecedented chiral binding pattern was observed for inhibitors of KRAS-PDEδ interactions. Virtual screening and X-ray crystallography studies revealed that two enantiomers of a racemic inhibitor could bind at different sites. Fragment-based drug design was used to identify highly potent PDEδ inhibitors that can be used as promising lead compounds for target validation and antitumor drug development.
科研通智能强力驱动
Strongly Powered by AbleSci AI